Cargando…
MiR-588 acts as an oncogene in ovarian cancer and increases the radioresistance of ovarian cancer cells
The therapeutic outcomes of ovarian cancer (OVCA) patients are majorly limited by the development of acquired chemo/radioresistance and the lack of targeted therapies. Accumulating studies demonstrate that microRNAs are involved in tumorigenesis and radioresistance. This study aims to illustrate the...
Autores principales: | Su, Xiaojuan, Wang, Binbin, Zhang, Bo, Pan, Shiwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214998/ https://www.ncbi.nlm.nih.gov/pubmed/37154623 http://dx.doi.org/10.1093/jrr/rrad033 |
Ejemplares similares
-
miR-588 is a prognostic marker in gastric cancer
por: Chen, Yongyi, et al.
Publicado: (2020) -
miR-214 promotes radioresistance in human ovarian cancer cells by targeting PETN
por: Zhang, Qin, et al.
Publicado: (2017) -
Circ_0010235 Regulates HOXA10 Expression to Promote Malignant Phenotypes and Radioresistance in Non-small Cell Lung Cancer Cells Via Decoying miR-588
por: Zhu, Hongyan, et al.
Publicado: (2022) -
lncRNA SNHG3 acts as oncogene in ovarian cancer through miR-139-5p and Notch1
por: Zhang, Li, et al.
Publicado: (2021) -
Plasma exosomal miR-320d, miR-4479, and miR-6763-5p as diagnostic biomarkers in epithelial ovarian cancer
por: Wang, Shiwen, et al.
Publicado: (2022)